http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4261986-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J3-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 |
| filingDate | 1979-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1981-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ca16fc26557ec43fad162f42d07f90 |
| publicationDate | 1981-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4261986-A |
| titleOfInvention | 4-Halo etianic acids and derivatives thereof |
| abstract | Certain 3-oxoandrost-4-ene and 3-oxoandrosta-1,4-diene 17 beta -carboxylic acids and esters substituted at the 4-position with a fluoro or chloro and optionally substituted at the six position with fluoro or chloro are useful as anti-inflammatory steroids. These compounds are optionally substituted at the 9 alpha -position with fluoro, chloro or bromo; substituted at the 11 with a keto, a beta -hydroxy or a beta -chloro (the latter only when there is a 9 alpha -chloro); substituted at 16 alpha (or 16 beta ) with methyl or hydrogen, and at 17 alpha with hydroxy or an ester. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646136-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4761285-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4587237-A |
| priorityDate | 1978-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 485.